Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models.
Acta Neuropathol. 2024 Mar 25;147(1):59. doi: 10.1007/s00401-024-02718-w.
Acta Neuropathol. 2024.
PMID: 38526686
No abstract available.
Single-cell transcriptomics reveal extracellular vesicles secretion with a cardiomyocyte proteostasis signature during pathological remodeling.
Schoger E, Bleckwedel F, Germena G, Rocha C, Tucholla P, Sobitov I, Möbius W, Sitte M, Lenz C, Samak M, Hinkel R, Varga ZV, Giricz Z, Salinas G, Gross JC, Zelarayán LC.
Schoger E, et al. Among authors: tucholla p.
Commun Biol. 2023 Jan 21;6(1):79. doi: 10.1038/s42003-022-04402-9.
Commun Biol. 2023.
PMID: 36681760
Free PMC article.
Item in Clipboard
Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N‑truncated Abeta in sporadic Alzheimer disease cases and mouse models.
Bouter Y, Lopez Noguerola JS, Tucholla P, Crespi GA, Parker MW, Wiltfang J, Miles LA, Bayer TA.
Bouter Y, et al. Among authors: tucholla p.
Acta Neuropathol. 2015 Nov;130(5):713-29. doi: 10.1007/s00401-015-1489-x.
Acta Neuropathol. 2015.
PMID: 26467270
Item in Clipboard
Cite
Cite